Advertisement

Lung Cancer

Nazartinib for Non-Small-Cell Lung Carcinoma

Non-small-cell lung carcinoma (NSCLC) is one of the most common types of lung cancers. The use of tyrosine kinase inhibitors (TKIs) is impeded by the emergence of the Thr790Met mutation in a majority of patients with epidermal...

Read More